Particle.news
Download on the App Store
61 ARTICLES
·
2h ago

WHO Issues Global Alert on Toxic Cough Syrups as Tamil Nadu Shuts Coldrif Maker

Tests found roughly 48% diethylene glycol in the pediatric syrup tied to at least 22 child deaths in Madhya Pradesh.

Saddam Mansuri, a father of two, holds up bottles of Coldrif and Relife cough syrup in Parasia, Madhya Pradesh, India, on October 10, 2025.
Image
Image
Image

Overview

  • The Enforcement Directorate searched seven locations in Chennai linked to Sresan Pharmaceuticals and senior Tamil Nadu drug control officials under a money-laundering probe.
  • Tamil Nadu revoked Sresan Pharmaceuticals’ manufacturing licence and ordered the company closed after inspectors documented more than 300 GMP and GLP violations.
  • WHO identified specific batches of three Indian syrups—Coldrif, Respifresh TR and ReLife—as contaminated products that pose severe risks to patients.
  • India’s drug regulator told WHO the contaminated syrups were not exported, while state authorities initiated recalls and widened inspections across manufacturing units.
  • Sresan owner G. Ranganathan was arrested by a Madhya Pradesh SIT and remanded to police custody as investigators trace distribution and potential proceeds of crime.